DK1336605T3 - Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X - Google Patents
Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor XInfo
- Publication number
- DK1336605T3 DK1336605T3 DK01997188T DK01997188T DK1336605T3 DK 1336605 T3 DK1336605 T3 DK 1336605T3 DK 01997188 T DK01997188 T DK 01997188T DK 01997188 T DK01997188 T DK 01997188T DK 1336605 T3 DK1336605 T3 DK 1336605T3
- Authority
- DK
- Denmark
- Prior art keywords
- salts
- coagulation factor
- inhibitors
- substituted phenol
- phenol derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Fats And Perfumes (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000356146 | 2000-11-22 | ||
JP2000390321 | 2000-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1336605T3 true DK1336605T3 (da) | 2006-06-19 |
Family
ID=26604464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01997188T DK1336605T3 (da) | 2000-11-22 | 2001-11-21 | Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X |
Country Status (17)
Country | Link |
---|---|
US (2) | US7504417B2 (pl) |
EP (1) | EP1336605B1 (pl) |
JP (1) | JP3903920B2 (pl) |
KR (1) | KR100863923B1 (pl) |
CN (1) | CN1283626C (pl) |
AT (1) | ATE323071T1 (pl) |
AU (2) | AU2002224064B2 (pl) |
CA (1) | CA2424522C (pl) |
DE (1) | DE60118774T2 (pl) |
DK (1) | DK1336605T3 (pl) |
ES (1) | ES2260336T3 (pl) |
HU (1) | HUP0400558A3 (pl) |
MX (1) | MXPA03003572A (pl) |
PL (1) | PL204898B1 (pl) |
PT (1) | PT1336605E (pl) |
RU (1) | RU2276137C2 (pl) |
WO (1) | WO2002042270A1 (pl) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
US7365205B2 (en) | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
PL369772A1 (pl) * | 2002-01-31 | 2005-05-02 | Morphochem Aktiengesellschaft Für Kombinatorischechemie | Związki hamujące aktywność czynnika XA |
GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
CA2554686A1 (en) * | 2004-02-18 | 2005-09-01 | Astrazeneca Ab | Compounds |
RU2392275C2 (ru) * | 2004-02-18 | 2010-06-20 | Астразенека Аб | Бензамидные производные и их применение в качестве активирующих глюкокиназу агентов |
TW200600086A (en) | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
BRPI0516595A (pt) * | 2004-10-16 | 2008-09-23 | Astrazeneca Ab | processo para fabricar um composto, e, composto |
GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
EP1847527A4 (en) | 2005-02-02 | 2009-04-08 | Ajinomoto Kk | NEW BENZAMIDINE DERIVATIVE |
WO2006125958A1 (en) * | 2005-05-24 | 2006-11-30 | Astrazeneca Ab | 2-phenyl substituted imidazol [4 , 5b] pyridine/ pyrazine and purine derivatives as glucokinase modulators |
TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
US20080234273A1 (en) * | 2005-07-09 | 2008-09-25 | Mckerrecher Darren | Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes |
KR101346902B1 (ko) * | 2005-07-09 | 2014-01-02 | 아스트라제네카 아베 | 당뇨병 치료에 있어 glk 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체 |
US20110053910A1 (en) * | 2005-07-09 | 2011-03-03 | Mckerrecher Darren | 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
TW200734304A (en) * | 2005-11-08 | 2007-09-16 | Astellas Pharma Inc | Benzene derivative or salt thereof |
TW200738621A (en) | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
TW200825060A (en) * | 2006-10-26 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
AU2007336016A1 (en) * | 2006-12-21 | 2008-06-26 | Astrazeneca Ab | Novel crystalline compound useful as GLK activator |
JP2010120852A (ja) * | 2007-03-09 | 2010-06-03 | Daiichi Sankyo Co Ltd | 新規なジアミド誘導体 |
WO2008135524A2 (en) * | 2007-05-02 | 2008-11-13 | Boehringer Ingelheim International Gmbh | Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments |
EP2311810A4 (en) | 2008-07-11 | 2012-04-04 | Ajinomoto Kk | AMIDINE DERIVATIVE |
EA201100097A1 (ru) | 2008-08-04 | 2011-10-31 | Астразенека Аб | Производные пиразоло[3,4]пиримидин-4-ила и их применения для лечения диабета и ожирения |
TW201021832A (en) * | 2008-09-30 | 2010-06-16 | Astellas Pharma Inc | Pharmaceutical composition for oral administration |
GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
AR076221A1 (es) * | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
AR076220A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivados de pirazol [4,5 - e] pirimidina |
DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
EP4070658A1 (de) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Verwendung von blutgerinnungshemmenden verbindungen als rodentizide |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04304012A (ja) * | 1991-03-31 | 1992-10-27 | Sony Corp | フイルタ回路 |
US5417200A (en) * | 1994-01-25 | 1995-05-23 | Wasielewski; John J. | Lantern cooker |
WO1996016940A1 (fr) | 1994-12-02 | 1996-06-06 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveau derive d'amidinonaphtyle ou sel de celui-ci |
IL133625A0 (en) * | 1997-06-26 | 2001-04-30 | Lilly Co Eli | Antithrombotic agents |
WO1999000126A1 (en) * | 1997-06-26 | 1999-01-07 | Eli Lilly And Company | Antithrombotic agents |
US6313122B1 (en) | 1997-06-26 | 2001-11-06 | Eli Lilly And Company | Antithrombotic agents |
DE69830504T2 (de) | 1997-06-26 | 2006-03-16 | Eli Lilly And Co., Indianapolis | Antithrombotische mitteln |
WO1999032477A1 (en) | 1997-12-19 | 1999-07-01 | Schering Aktiengesellschaft | Ortho-anthranilamide derivatives as anti-coagulants |
US6140351A (en) | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
WO1999037643A1 (fr) | 1998-01-26 | 1999-07-29 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveaux derives heterocycliques a fusion benzenique ou sels de ceux-ci |
ATE272633T1 (de) | 1998-12-23 | 2004-08-15 | Lilly Co Eli | Aromatische amiden |
CA2358091A1 (en) * | 1998-12-23 | 2000-07-06 | Eli Lilly And Company | Antithrombotic amides |
ES2196917T3 (es) | 1998-12-23 | 2003-12-16 | Lilly Co Eli | Amidas heteroaromaticas como inhibidores del factor xa`. |
JP4390024B2 (ja) | 1999-04-23 | 2009-12-24 | アステラス製薬株式会社 | 新規なジアゼパン誘導体又はその塩 |
CZ2002959A3 (cs) | 1999-09-17 | 2002-07-17 | Millennium Pharmaceuticals, Inc. | Inhibitory faktoru Xa |
ES2316383T3 (es) | 1999-09-17 | 2009-04-16 | Millennium Pharmaceuticals, Inc. | Benzamidas e inhibidores relacionados del factor xa. |
US6632815B2 (en) | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
CA2401778C (en) | 2000-02-29 | 2010-12-21 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
AU776053B2 (en) | 2000-03-31 | 2004-08-26 | Astellas Pharma Inc. | Diazepan derivatives or salts thereof |
ATE374765T1 (de) | 2000-07-27 | 2007-10-15 | Lilly Co Eli | Substituierte heterocyclische amide |
AU2001297648A1 (en) | 2000-11-28 | 2002-08-28 | Eli Lilly And Company | Substituted carboxamides as inhibitors of factor xa |
-
2001
- 2001-11-21 WO PCT/JP2001/010176 patent/WO2002042270A1/ja active IP Right Grant
- 2001-11-21 HU HU0400558A patent/HUP0400558A3/hu unknown
- 2001-11-21 DE DE60118774T patent/DE60118774T2/de not_active Expired - Lifetime
- 2001-11-21 ES ES01997188T patent/ES2260336T3/es not_active Expired - Lifetime
- 2001-11-21 RU RU2003115092/04A patent/RU2276137C2/ru not_active IP Right Cessation
- 2001-11-21 KR KR1020037006813A patent/KR100863923B1/ko not_active IP Right Cessation
- 2001-11-21 DK DK01997188T patent/DK1336605T3/da active
- 2001-11-21 CA CA002424522A patent/CA2424522C/en not_active Expired - Fee Related
- 2001-11-21 EP EP01997188A patent/EP1336605B1/en not_active Expired - Lifetime
- 2001-11-21 PL PL360710A patent/PL204898B1/pl not_active IP Right Cessation
- 2001-11-21 CN CNB018192564A patent/CN1283626C/zh not_active Expired - Fee Related
- 2001-11-21 JP JP2002544406A patent/JP3903920B2/ja not_active Expired - Fee Related
- 2001-11-21 MX MXPA03003572A patent/MXPA03003572A/es active IP Right Grant
- 2001-11-21 US US10/399,625 patent/US7504417B2/en not_active Expired - Fee Related
- 2001-11-21 AU AU2002224064A patent/AU2002224064B2/en not_active Ceased
- 2001-11-21 AU AU2406402A patent/AU2406402A/xx active Pending
- 2001-11-21 PT PT01997188T patent/PT1336605E/pt unknown
- 2001-11-21 AT AT01997188T patent/ATE323071T1/de active
-
2009
- 2009-01-20 US US12/356,376 patent/US7786106B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2276137C2 (ru) | 2006-05-10 |
CN1283626C (zh) | 2006-11-08 |
JPWO2002042270A1 (ja) | 2004-03-25 |
ES2260336T3 (es) | 2006-11-01 |
CA2424522C (en) | 2009-12-29 |
US20040077555A1 (en) | 2004-04-22 |
JP3903920B2 (ja) | 2007-04-11 |
WO2002042270A1 (fr) | 2002-05-30 |
EP1336605A1 (en) | 2003-08-20 |
DE60118774D1 (de) | 2006-05-24 |
HUP0400558A2 (hu) | 2004-06-28 |
CA2424522A1 (en) | 2003-03-31 |
DE60118774T2 (de) | 2007-03-15 |
ATE323071T1 (de) | 2006-04-15 |
EP1336605A4 (en) | 2004-01-28 |
PT1336605E (pt) | 2006-06-30 |
EP1336605B1 (en) | 2006-04-12 |
KR20030060944A (ko) | 2003-07-16 |
AU2406402A (en) | 2002-06-03 |
PL360710A1 (pl) | 2004-09-20 |
MXPA03003572A (es) | 2003-07-14 |
US7786106B2 (en) | 2010-08-31 |
AU2002224064B2 (en) | 2005-12-08 |
HUP0400558A3 (en) | 2010-03-29 |
PL204898B1 (pl) | 2010-02-26 |
US20090137498A1 (en) | 2009-05-28 |
CN1476433A (zh) | 2004-02-18 |
KR100863923B1 (ko) | 2008-10-17 |
US7504417B2 (en) | 2009-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1336605T3 (da) | Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X | |
ATE227306T1 (de) | Thrombin-inhibitoren als anticoagulierende mittel | |
DK0976722T3 (da) | Benzamidin-derivater | |
ES2531660T3 (es) | Compuestos novedosos que tienen actividad inhibidora frente a transportador de glucosa dependiente de sodio | |
BR0209468A (pt) | Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar | |
TR200002965T2 (tr) | Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı | |
BR0111196A (pt) | Composições e uso das mesmas para tratamento de flavivìrus e pestivìrus | |
ECSP034774A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
ES2120132T3 (es) | Aductos de bisulfito de argininaldehidos utiles como inhibidores de la trombina y anticoagulantes. | |
BR9806752A (pt) | Ftalazinonas. | |
NO20032488D0 (no) | Orto-substituerte nitrogen-inneholdende bisarylforbindelser anvendt som kaliumkanalinhibitorer | |
DK0558529T3 (da) | Farmaceutisk præparat til behandling af forlænget koagulationstid | |
DK1427409T3 (da) | Fremgangsmåde til behandling eller forhindring af vaskulær inflammation under brug af en eller flere sterolabssorptionsinhibitorer | |
CO5070657A1 (es) | Composiciones farmaceuticas para tratar infecciones virales y metodo para hacerlas | |
EP1065200A4 (en) | Aminoisoquinoline DERIVATIVES | |
PA8466101A1 (es) | Agentes terapeuticos | |
DE69906568D1 (de) | Behandlung von hämorrhagischem virusfieber mit protein c | |
BR0113212A (pt) | Composto, formulação farmacêutica, uso de um composto ou de um seu derivado farmaceuticamente aceitável, métodos de tratamento de uma condição em que a inibição da trombina é requerida, e de uma condição em que a terapia anticoagulante é indicada, e, processo para a preparação de um composto | |
ATE498305T1 (de) | Vermeidung und behandlung von krankheiten, die mit der blutgerinnung in zusammenhang stehen | |
DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
DK1133314T3 (da) | Protein C til behandling af seglcellesygdom og thalassæmi | |
BR0015402A (pt) | Derivados de ácido 15-hidroxieicosatetraenóico de cadeia Èmega modificada e métodos de seu uso para o tratamento de olho seco | |
NO20012308D0 (no) | Kombinasjon av riluzol og alfatokoferol | |
BR0012072A (pt) | Processo para o tratamento ou prevenção de vasoespasmo de enxerto coronário |